Item 5.02 Departure of Directors or Certain Officers; Election of Directors;

Appointment of Certain Officers; Compensatory Arrangements of Certain

Officers.

As previously disclosed, on December 22, 2021, the Board of Directors (the "Board") of Sanara MedTech Inc. (the "Company") appointed Mr. Zachary B. Fleming as the Chief Executive Officer of the Company, effective January 1, 2022.

In connection with Mr. Fleming's appointment as Chief Executive Officer of the Company, effective January 1, 2022, the Board granted Mr. Fleming a one-time restricted stock award of 10,000 shares of the Company's common stock, which such shares will vest in three equal installments on January 1, 2023, 2024 and 2025.

© Edgar Online, source Glimpses